Nuclear ASCL1 expression seems to persist in neuroendocrine prostate cancer cells and, moreover, DCX-positive neural progenitors from the central nervous system have been demonstrated to infiltrate prostate tumours and metastases and initiate tumour neurogenesis, thus contributing to the stabilization and promotion of neuroendocrine phenotype [106,149]. Here, DCX is linked to prostate cancer.